For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Cell Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 103

% Expired Patents = 20.4

EPO Patents = 4

Trademarks = 5

Forward Citations = 1,049

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

J Peter Klein (50 out of 50 patents)

Gail E Underiner (33 out of 33 patents)

Anil M Kumar (28 out of 37 patents)

4. Jack W Singer (25 out of 28 patents)

5. David J Porubek (21 out of 25 patents)

6. David W Leung (20 out of 28 patents)

7. Paul Woodson (18 out of 18 patents)

8. Alistair J Leigh (15 out of 15 patents)

9. Glenn C Rice (12 out of 14 patents)

10. James A Bianco (12 out of 15 patents)

11. Baoqing Gong (10 out of 10 patents)

12. John Michnick (9 out of 9 patents)

13. John E Tulinsky (9 out of 11 patents)

14. Stuart L Bursten (8 out of 10 patents)

15. David M Hollenback (7 out of 7 patents)

Core Competencies:

Neurotrophic Agents

Tumor Necrosis Factor Inhibitors

Polyglutamic Acid

Biologically Active Polypeptides

Prostaglandins

Xanthine Compounds

Angiogenic Lipids

LPAAT-β Inhibitors

Therapeutic Compounds

Ocular Hypertension

Tricyclic Compounds

Cell Proliferation

103 patents: Sort by Forward Citations

1. 12128104 - Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor (2024-10-29),

2. 11147855 - Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour (2021-10-19),

3. 8748577 - Conjugates of biologically active polypeptides having an increased in vivo half-life (2014-06-10),

4. 8426625 - Bis-platinum complexes with antitumor activity (2013-04-23),

5. 8415338 - Oxygen linked pyrimidine derivatives (2013-04-09),

6. 8329853 - Process for the preparation of poly-α-glutamic acid and derivatives thereof (2012-12-11),

7. 8318503 - Method for determining the amount of conjugated taxane in polyglut acid-taxane conjugates (2012-11-27),

8. 8129348 - Conjugates of biologically active proteins having a modified in vivo half-life (2012-03-06),

9. 7618968 - Aryl triazines as LPAAT-β inhibitors and uses thereof (2009-11-17),

10. 7608620 - LPAAT-β inhibitors and uses thereof (2009-10-27),

11. 7419984 - Pyrimidines and uses thereof (2008-09-02),

12. 7399860 - Manufacture of polyglutamate-therapeutic agent conjugates (2008-07-15),

13. 7291616 - Aryl triazines as LPAAT-β inhibitors and uses thereof (2007-11-06),

14. 7247630 - Uses of tricyclic compounds (2007-07-24),

15. 7208507 - Pyridines and uses thereof (2007-04-24),

Company Overview

Cell Therapeutics, Inc., based in Seattle, WA, specializes in the development of innovative drug delivery systems aimed at treating various medical conditions. The company focuses on advanced therapeutic agents, including neurotrophic agents and tumor necrosis factor inhibitors, to enhance patient outcomes. Its research encompasses a range of core technologies, such as biologically active polypeptides and angiogenic lipids, positioning it at the forefront of therapeutic advancements in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

103 Patents

#20 in Seattle, WA

#63 in Washington

#3,695 in US

#7,592 in the World

Seattle, WA, United States of America

Cell Therapeutics, Inc.

Forward Citations = 1,049

75 inventors:

J Peter Klein (50 out of 50 patents)

Gail E Underiner (33 out of 33 patents)

Anil M Kumar (28 out of 37 patents)

4. Jack W Singer (25 out of 28 patents)

5. David J Porubek (21 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cell Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cell-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…